CA2174731A1 - Derives de rapamycine utilises comme immonosuppresseurs - Google Patents

Derives de rapamycine utilises comme immonosuppresseurs

Info

Publication number
CA2174731A1
CA2174731A1 CA002174731A CA2174731A CA2174731A1 CA 2174731 A1 CA2174731 A1 CA 2174731A1 CA 002174731 A CA002174731 A CA 002174731A CA 2174731 A CA2174731 A CA 2174731A CA 2174731 A1 CA2174731 A1 CA 2174731A1
Authority
CA
Canada
Prior art keywords
immunosuppressants
derivatives useful
rapamycin derivatives
formula
rapamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002174731A
Other languages
English (en)
Other versions
CA2174731C (fr
Inventor
Sylvain Cottens
Richard Sedrani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939325802A external-priority patent/GB9325802D0/en
Priority claimed from GB939325800A external-priority patent/GB9325800D0/en
Priority claimed from GB9407138A external-priority patent/GB9407138D0/en
Priority claimed from GB9421982A external-priority patent/GB9421982D0/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1994/004191 external-priority patent/WO1995016691A1/fr
Publication of CA2174731A1 publication Critical patent/CA2174731A1/fr
Application granted granted Critical
Publication of CA2174731C publication Critical patent/CA2174731C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002174731A 1993-12-17 1994-12-16 Derives de rapamycine utilises comme immonosuppresseurs Expired - Fee Related CA2174731C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB939325802A GB9325802D0 (en) 1993-12-17 1993-12-17 Organic compounds
GB939325800A GB9325800D0 (en) 1993-12-17 1993-12-17 Organic compounds
GB9407138A GB9407138D0 (en) 1994-04-11 1994-04-11 Organic compounds
GB9325800.2 1994-11-01
GB9421982A GB9421982D0 (en) 1994-11-01 1994-11-01 Organic compounds
GB9407138.8 1994-11-01
GB9421982.1 1994-11-01
GB9325802.8 1994-11-01
PCT/EP1994/004191 WO1995016691A1 (fr) 1993-12-17 1994-12-16 Derives de rapamycine utilises comme immonosuppresseurs

Publications (2)

Publication Number Publication Date
CA2174731A1 true CA2174731A1 (fr) 1995-06-22
CA2174731C CA2174731C (fr) 2006-10-31

Family

ID=37395713

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002174731A Expired - Fee Related CA2174731C (fr) 1993-12-17 1994-12-16 Derives de rapamycine utilises comme immonosuppresseurs

Country Status (1)

Country Link
CA (1) CA2174731C (fr)

Also Published As

Publication number Publication date
CA2174731C (fr) 2006-10-31

Similar Documents

Publication Publication Date Title
CA2145383A1 (fr) Derives de rapamycine alkyles en o et leur utilisation, principalement comme immunosupresseurs
CA2475113A1 (fr) Derives isothiazole utiles en tant qu'agents anticancereux
NO962540L (no) Rapamycinderivater for anvendelse som immunsuppresjonsmidler
WO2002076995A3 (fr) Derives de 2-amino-propanol
CA2276455A1 (fr) Phthalazinones
CA2135751A1 (fr) Derives de 4-mercaptoacetylamino-[2] benzazepinone(3) et leur utilisation comme inhibiteurs de l'enkephalinase
CA2123052A1 (fr) Derives monomeriques d'acides biliaires, methodes pour les preparer et utilisation a titre de medicaments
CA2157117A1 (fr) Derives spirocycliques de la piperidine
CA2352505A1 (fr) Derives d'epothilone et leur utilisation comme agents antitumoraux
CA2160137A1 (fr) Ansamycines bicycliques
CA2275635A1 (fr) 1-arylpyrazoles pesticides
CA2103861A1 (fr) Nouveau 7-(substituant)-8-(substituant-9-(amino substitue)-6-demethyl-6-desoxytetracyclines
CA2270964A1 (fr) Benzonaphtyridines en tant que agents therapeutiques bronchiques
CA2146852A1 (fr) Nouveaux derives de substitution du pyrazole; methode de preparation; utilisation comme herbicides
CA2274464A1 (fr) Cetobenzamides s'utilisant comme inhibiteurs de la calpaine
CA2106200A1 (fr) Preparation stereoselective de piperidines substituees
CA2109934A1 (fr) Utilisation d'indoles substituees comme composes pharmaceutiques anti-sida
CA2243504A1 (fr) Nouveaux derives de 19-nor-pregnene
CA2048110A1 (fr) Derives d'imidazopyridine et leur utilisation
CA2130116A1 (fr) Derives de l'aminoacetylmercaptoacetylamide utilises en tant qu'inhibiteurs de l'enkephalinase et de l'acetylcholinesterase
CA2388476A1 (fr) Derives d'imidazo-5-yl-amine bicycliques
CA2188580A1 (fr) Heterocycles n-cyanoaryle-azote
CA2080249A1 (fr) Obtention de piperidines a substituant
CA2133885A1 (fr) Complexe d'inclusion cristalline de diclofenac avec beta-cyclodextrine
CA2138289A1 (fr) Derives azabicycloheptane substitues en n, leur preparation et leur utilisation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed